3rd Next Generation Lipid-Based Nanoparticles Delivery Summit
Evvnt Promotion / evvnt
Archivio
20.08.2024 - 22.08.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:30 AM - 5:00 PM
Temi della conferenza
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832
Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832
Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2315995-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
